BidaskClub upgraded shares of Utah Medical Products, Inc. (NASDAQ:UTMD) from a sell rating to a hold rating in a report issued on Wednesday morning.

Separately, ValuEngine upgraded Utah Medical Products from a sell rating to a hold rating in a research note on Tuesday, June 6th.

Shares of Utah Medical Products (NASDAQ:UTMD) traded down 3.62% during midday trading on Wednesday, hitting $69.30. The stock had a trading volume of 11,319 shares. Utah Medical Products has a 12-month low of $56.30 and a 12-month high of $75.00. The firm has a 50-day moving average of $71.40 and a 200 day moving average of $65.46. The firm has a market cap of $257.73 million, a PE ratio of 19.87 and a beta of 0.74.

COPYRIGHT VIOLATION NOTICE: “Utah Medical Products, Inc. (NASDAQ:UTMD) Raised to Hold at BidaskClub” was originally published by TheOlympiaReport and is owned by of TheOlympiaReport. If you are accessing this piece of content on another publication, it was stolen and reposted in violation of US & international trademark and copyright laws. The original version of this piece of content can be viewed at https://theolympiareport.com/2017/08/12/utah-medical-products-inc-nasdaqutmd-raised-to-hold-at-bidaskclub.html.

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, October 3rd. Shareholders of record on Friday, September 15th will be given a $0.265 dividend. The ex-dividend date of this dividend is Thursday, September 14th. This represents a $1.06 dividend on an annualized basis and a dividend yield of 1.53%. Utah Medical Products’s dividend payout ratio is currently 30.37%.

Several hedge funds have recently made changes to their positions in the company. Martingale Asset Management L P boosted its position in shares of Utah Medical Products by 32.9% in the second quarter. Martingale Asset Management L P now owns 10,901 shares of the medical instruments supplier’s stock worth $790,000 after buying an additional 2,700 shares during the last quarter. Seizert Capital Partners LLC boosted its position in shares of Utah Medical Products by 5.2% in the second quarter. Seizert Capital Partners LLC now owns 6,512 shares of the medical instruments supplier’s stock worth $471,000 after buying an additional 320 shares during the last quarter. Brandes Investment Partners LP bought a new position in shares of Utah Medical Products during the second quarter worth about $2,833,000. Prudential Financial Inc. bought a new position in shares of Utah Medical Products during the second quarter worth about $233,000. Finally, WCM Investment Management CA boosted its position in shares of Utah Medical Products by 0.9% in the second quarter. WCM Investment Management CA now owns 81,912 shares of the medical instruments supplier’s stock worth $5,930,000 after buying an additional 695 shares during the last quarter. Institutional investors own 65.51% of the company’s stock.

Utah Medical Products Company Profile

Utah Medical Products, Inc (UTMD) is engaged in the business of producing medical devices that are disposable and for hospital use. The Company’s product categories include labor and delivery/obstetrics, including fetal monitoring accessories, Vacuum-Assisted Delivery Systems (VAD), and other labor and delivery tools; neonatal intensive care, including DISPOSA-HOOD, DELTRAN PLUS and GESCO; gynecology/urology/electrosurgery, including LETZ System, FINESSE+ Generator, EPITOME, PATHFINDER PLUS, HOLMIUM LASER FIBRES, LIBERTY System, ENDOCURETTE, TVUS/HSG-Cath and LUMIN, and blood pressure monitoring, including DELTRAN Disposable Pressure Transducer (DPT), and pressure monitoring accessories, components and other molded parts.

Receive News & Ratings for Utah Medical Products Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Utah Medical Products Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.